Krause v. Du Pont Pharmaceuticals, Inc.

603 N.E.2d 851, 237 Ill. App. 3d 254, 177 Ill. Dec. 781, 1992 Ill. App. LEXIS 1881
CourtAppellate Court of Illinois
DecidedNovember 19, 1992
DocketNo. 5—91—0278
StatusPublished

This text of 603 N.E.2d 851 (Krause v. Du Pont Pharmaceuticals, Inc.) is published on Counsel Stack Legal Research, covering Appellate Court of Illinois primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Krause v. Du Pont Pharmaceuticals, Inc., 603 N.E.2d 851, 237 Ill. App. 3d 254, 177 Ill. Dec. 781, 1992 Ill. App. LEXIS 1881 (Ill. Ct. App. 1992).

Opinion

JUSTICE H. LEWIS

delivered the opinion of the court:

In December of 1989 a complaint was filed in the circuit court of Madison County on behalf of David Paul Krause, Jr., by his mother and next friend, Diana Krause, and by Diana Krause individually against various defendants, including Du Pont Pharmaceuticals, Inc. (Du Pont). The trial court granted Du Font’s motion to dismiss the count brought by Diana Krause individually against that defendant. In this appeal we are not concerned with any of the several other counts of the complaint. The trial court found that the action against Du Pont was barred by the statute of limitations and dismissed the claim against DuPont in this litigation. The trial court found there was no just reason for delaying enforcement or appeal. A timely notice of appeal was filed pursuant to Supreme Court Rule 304(a) (134 Ill. 2d R. 304(a)). The only question before this court is whether the circuit court properly dismissed the plaintiff’s December 1989 claim against Du Pont as time barred.

The court considered the complaint, as amended, the motion to dismiss with attached exhibits, affidavits and documentation, and memoranda furnished by counsel. The defendants filed a motion to dismiss pursuant to section 2—619 of the Code of Civil Procedure (Ill. Rev. Stat. 1991, ch. 110, par. 2—619), which states in pertinent part:

“Involuntary dismissal based upon certain defects or defenses. (a) Defendant may, within the time for pleading, file a motion for dismissal of the action or for other appropriate relief upon any of the following grounds. If the grounds do not appear on the face of the pleading attacked the motion shall be supported by affidavit:
* * *
(5) That the action was not commenced within the time limited by law.
* * *
(c) If, upon the hearing of the motion, the opposite party presents affidavits or other proof denying the facts alleged or establishing facts obviating the grounds of defect, the court may hear and determine the same and may grant or deny the motion. If a material and genuine disputed question of fact is raised the court may decide the motion upon the affidavits and evidence offered by the parties, or may deny the motion without prejudice to the right to raise the subject matter of the motion by answer and shall so deny it if the action is one in which a party is entitled to a trial by jury and a jury demand has been filed by the opposite party in apt time.”

The applicable statute of limitations (Ill. Rev. Stat. 1989, ch. 110, par. 13—213(d)) provides in relevant part:

“Notwithstanding the provisions of subsection (b) and paragraph (2) of subsection (c) if the injury complained of occurs within any of the periods provided by subsection (b) and paragraph (2) of subsection (c), the plaintiff may bring an action within 2 years after the date on which the claimant knew, or through the use of reasonable diligence should have known, of the existence of the personal injury, death or property damage, but in no event shall such action be brought more than 8 years after the date on which such personal injury, death or property damage occurred.”

The plaintiff contends on appeal that her cause of action against DuPont is not barred by the statute of limitations and the trial court should not have dismissed count II for that reason.

David P. Krause, Jr., was born on December 6, 1981, and suit was filed in December of 1989. Count II of Diana Krause’s initial complaint was dismissed on the grounds that she had not properly pleaded facts invoking the “discovery rule” of section 13—213(d). In an effort to comply with this rule, the plaintiff alleged the following in her second amended complaint:

“7. Diana Krause did not know and could not have reasonably discovered that David P. Krause, Jr. suffered from Coumadin related symptoms and defects prior to two years before this lawsuit was filed. Specifically, Diana Krause was never told by any doctors that David P. Krause, Jr.’s problems were caused by Coumadin; Diana Krause had no medical training that would have allowed her to come to this conclusion on her own; Diana Krause had not reviewed any medical records from David P. Krause, Jr.’s treatment that could have indicated to her that her son’s condition was caused from Coumadin. As a result, Diana Krause had no reason to be suspicious that David Krause’s problems were caused by Coumadin and had no way to independently discovery [sic] that her son’s problems were Coumadin related prior to two years before this lawsuit was filed. Further, DuPont never informed Diana Krause of the problems associated with Coumadin taken during pregnancy.”

It appears from the record that Diana became pregnant in 1981 and that prior thereto in February of 1981 Dr. Greaves had treated her for blood clots in her legs by prescribing Coumadin. Dr. Greaves told Diana not to become pregnant and to stop taking Coumadin if she became pregnant. In June or July of 1981 Diana suspected that she was pregnant and stated that she had stopped taking Coumadin “right then.” Her pregnancy was confirmed by Dr. Petroff. Dr. Greaves wrote her a letter in July of 1981 in which he told her that if she was pregnant, she should not take Coumadin.

On December 6, 1981, Diana gave birth to David, who, according to his mother, had problems immediately. He was born prematurely by breech delivery and suffered from birth trauma and blood clots as well as respiratory and numerous other problems, including cerebral palsy and the need for a heart shunt. He developed unusual features commonly associated with the mother’s ingestion of Coumadin during pregnancy.

In 1984 or 1985 Diana was again treated for blood clots and resumed taking Coumadin. While in the hospital during this illness, she was given two DuPont pamphlets regarding Coumadin, which she retained. She stated that she had read the pamphlets but that she had not been concerned about the contents because she could no longer become pregnant. According to her testimony, the pamphlets made her think it was dangerous to take Coumadin during pregnancy. She further testified that no one, including her doctor or personnel of Cardinal Glennon Hospital, specifically told her that the child’s problems at birth might have been caused by Coumadin. The medical records of her child documented suspected Coumadinrelated malformations. However, she never had access to these records and did not examine them.

In Witherell v. Weimer (1981), 85 Ill. 2d 146, 421 N.E.2d 869, the court stated:

“The statute starts to run when a person knows or reasonably should know of his injury and also knows or reasonably should know that it was wrongfully caused. At that point the burden is upon the injured person to inquire further as to the existence of a cause of action. (United States v. Kubrick (1979), 444 U.S. 111, 62 L. Ed. 2d 259, 100 S. Ct. 352; Urchel v. Holy Cross Hospital (1980), 82 Ill. App. 3d 1050, 1052-53; Gaudynski v. Corbett (1980), 81 Ill. App. 3d 910, 913-14; Ikenn v. Northwestern Memorial Hospital (1979), 73 Ill. App.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

United States v. Kubrick
444 U.S. 111 (Supreme Court, 1979)
Cuerton v. American Hospital Supply Corp.
482 N.E.2d 187 (Appellate Court of Illinois, 1985)
Berry v. G. D. Searle & Co.
309 N.E.2d 550 (Illinois Supreme Court, 1974)
Greenock v. Rush Presbyterian St. Luke's Medical Center
382 N.E.2d 321 (Appellate Court of Illinois, 1978)
Zagar v. Health & Hospitals Governing Commission
404 N.E.2d 496 (Appellate Court of Illinois, 1980)
Ruklick v. Julius Schmid, Inc.
523 N.E.2d 1208 (Appellate Court of Illinois, 1988)
Kielminski v. St. Anthony's Hospital
386 N.E.2d 326 (Appellate Court of Illinois, 1979)
Lipsey v. Michael Reese Hospital
262 N.E.2d 450 (Illinois Supreme Court, 1970)
Urchel v. Holy Cross Hospital
403 N.E.2d 545 (Appellate Court of Illinois, 1980)
Ikenn v. Northwestern Memorial Hospital
392 N.E.2d 440 (Appellate Court of Illinois, 1979)
Gaudynski v. Corbett
401 N.E.2d 1218 (Appellate Court of Illinois, 1980)
Blair v. Blondis
513 N.E.2d 157 (Appellate Court of Illinois, 1987)
Witherell v. Weimer
421 N.E.2d 869 (Illinois Supreme Court, 1981)
State v. Caldwell
483 N.E.2d 187 (Ohio Court of Appeals, 1984)
Society of Mount Carmel v. Fox
413 N.E.2d 480 (Appellate Court of Illinois, 1980)

Cite This Page — Counsel Stack

Bluebook (online)
603 N.E.2d 851, 237 Ill. App. 3d 254, 177 Ill. Dec. 781, 1992 Ill. App. LEXIS 1881, Counsel Stack Legal Research, https://law.counselstack.com/opinion/krause-v-du-pont-pharmaceuticals-inc-illappct-1992.